ZELTIQ
Zeltiq Aesthetics Inc (Form: 10-K/A, Received: 08/07/2013 16:19:20)
Table of Contents

 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
____________________________________________
FORM 10-K/A
(Amendment No. 1)
____________________________________________
(Mark One)
ý
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 2012
OR
¨
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period             to             .
Commission file number: 001-35318
____________________________________________
ZELTIQ Aesthetics, Inc.
(Exact name of registrant as specified in its charter)
____________________________________________
Delaware
 
27-0119051
(State or other jurisdiction of
incorporation or organization)
 
(I.R.S. employer
identification no.)
4698 Willow Road, Suite 100
Pleasanton, CA 94588
(Address of principal executive offices and Zip Code)
(925) 474-2500
(Registrant’s telephone number, including area code)
____________________________________________
Securities registered pursuant to Section 12(b) of the Act:
Title of each class: Common Stock
Name of each exchange on which registered: The NASDAQ Global Select Market
Securities registered pursuant to Section 12(g) of the Act: None
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.    Yes   ¨     No   x
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Exchange Act.    Yes   ¨     No   x
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes   ý     No   ¨
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes   ý     No   ¨
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K    ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act (check one):
 
Large accelerated filer
 
¨
  
Accelerated filer
 
ý
Non-accelerated filer
 
¨
  
Smaller reporting company
 
¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act.):    Yes   ¨     No   ý
Aggregate market value of registrant's common stock held by non-affiliates of the registrant, based upon the closing price of a share of the registrant's common stock on June 29, 2012 (the last business day of the registrant's most recently completed second quarter) as reported by NASDAQ Global Select Market on that date: $77,215,130 . Shares of the registrant's common stock held by each executive officer, director and person who owns 15% or more of the outstanding common stock of the registrant have been excluded in that such persons may be deemed to be affiliates. This determination of affiliate status is not necessarily a conclusive determination for other purposes.
As of March 6, 2013 , there were 35,896,740 shares of the registrant’s common stock, par value $0.001 per share, outstanding.
DOCUMENTS INCORPORATED BY REFERENCE
None

EXPLANATORY NOTE
On March 13, 2013, we filed our Form 10-K for the period ended December 31, 2012 (“Original Annual Report”).  This Amendment No. 1 to Form 10-K is filed solely to refile corrected Exhibits 31.1 and 31.2 (which corrected exhibits filed herewith are dated as of the date of the original exhibits) to the Form 10-K in accordance with Item 601(b)(31) of Regulation S-K.

Except as described above, no attempt has been made in this Amendment to modify or update any disclosures presented in the Original Annual Report other than as revised in the Exhibit Index. This Amendment No.1 does not reflect events occurring after the filing of the Original Annual Report or modify or update any disclosures therein. Accordingly, this Amendment should be read in conjunction with the Company's filings with the Securities and Exchange Commission subsequent to the filing of the Original Annual Report, including any amendments to those filings.

Pursuant to Rule 12b-15 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), the Company has filed the certifications required by Rule 13a-14(a) or 15d-14(a) of the Exchange Act.

 


Table of Contents

ZELTIQ Aesthetics, Inc.

FORM 10-K/A
(Amendment No. 1)
For the Year Ended December 31, 2012
TABLE OF CONTENTS
 
 
 
PAGE
NUMBER
 

2

Table of Contents

SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
 
ZELTIQ Aesthetics, Inc.
 
 
 
 
Date:
August 7, 2013
By:
/s/ Mark J. Foley
 

 
Mark J. Foley
 
 
 
President and Chief Executive Officer
 
 
 
(Principal Executive Officer)
 
 
 
 



3

Table of Contents

EXHIBIT INDEX
(To Original Filing)

 
 
 
 
 
 
 
Incorporated by Reference
Exhibit No.
 
Description
 
Filed with Original Filing
 
Form
 
File No.
 
Exhibit No.
 
Date Filed
3.1

 
Amended and Restated Certificate of Incorporation of ZELTIQ Aesthetics, Inc.
 
 
 
S-1
 
333-175514
 
3.2

 
7/13/2011
3.2

 
Amended and Restated Bylaws of ZELTIQ Aesthetics, Inc.
 
 
 
S-1
 
333-175514
 
3.4

 
7/13/2011
4.1

 
Reference is made to Exhibits 3.1 and 3.2.
 
 
 
 
 
 
 
 
 
 
4.2

 
Form of Stock Certificate.
 
 
 
S-1/A
 
333-175514
 
4.1

 
9/23/2011
4.3

 
Warrant to Purchase Stock, dated as of January 14, 2009, by and between ZELTIQ Aesthetics, Inc. and Silicon Valley Bank.
 
 
 
S-1
 
333-175514
 
4.2

 
7/13/2011
10.1

#
Amended and Restated Exclusive License Agreement, dated September 21, 2011, by and between ZELTIQ Aesthetics, Inc. (as successor in interest to Juniper Medical, Inc.) and The General Hospital Corporation d/b/a Massachusetts General Hospital.
 
 
 
S-1/A
 
333-175514
 
10.4

 
10/11/2011
10.2

 
Office Building Lease, dated December 22, 2006, by and between ZELTIQ Aesthetics, Inc. (as successor in interest to Juniper Medical, Inc.) and Hacienda Portfolio Venture LLC (as successor in interest to Crosstown Ventures II, LLC).
 
 
 
S-1/A
 
333-175514
 
10.4

 
8/17/2011
10.3

 
First Amendment to Office Building Lease, dated December 22, 2006, by and between ZELTIQ Aesthetics, Inc. (as successor in interest to Juniper Medical, Inc.) and Hacienda Portfolio Venture LLC (as successor in interest to Crosstown Ventures II, LLC).
 
 
 
S-1/A
 
333-175514
 
10.5

 
8/17/2011
10.4

 
Second Amendment to Office Building Lease, dated September 24, 2010, by and between ZELTIQ Aesthetics, Inc. (as successor in interest to Juniper Medical, Inc.) and Hacienda Portfolio Venture LLC (as successor in interest to Crosstown Ventures II, LLC).
 
 
 
S-1/A
 
333-175514
 
10.6

 
8/17/2011
10.5

 
Loan and Security Agreement, dated January 14, 2009, by and between ZELTIQ Aesthetics, Inc. and Silicon Valley Bank.
 
 
 
S-1
 
333-175514
 
10.7

 
7/13/2011
10.6

 
First Amendment to Loan and Security Agreement, dated July 28, 2009, by and between ZELTIQ Aesthetics, Inc. and Silicon Valley Bank.
 
 
 
S-1
 
333-175514
 
10.8

 
7/13/2011
10.8

 
Manufacturing Services Agreement, dated April 16, 2010, by and between ZELTIQ Aesthetics, Inc. and ONCORE Manufacturing, LLC.
 
 
 
S-1/A
 
333-175514
 
10.9

 
8/17/2011
10.9

 
Third Amended and Restated Investor Rights Agreement, dated May 26, 2010, by and among ZELTIQ Aesthetics, Inc. and the individuals and entities listed on Exhibit A attached thereto.
 
 
 
S-1
 
333-175514
 
10.23

 
7/13/2011
10.10

 
Manufacturing Services Agreement, dated December 7, 2010, by and between ZELTIQ Aesthetics, Inc. and UNICEP Packaging Inc.
 
 
 
S-1
 
333-175514
 
10.10

 
7/13/2011

4

Table of Contents

10.11

 
Form of Purchase Order (used for each of Katecho, Inc., Coastline International, Inc., Renesas Electronics Corporation, and Hypertronics Corporation).
 
 
 
S-1/A
 
333-175514
 
10.2

 
8/17/2011
10.13

*
Form of Indemnification Agreement, by and between ZELTIQ Aesthetics, Inc. and each of its directors and officers.
 
 
 
S-1
 
333-175514
 
10.17

 
7/13/2011
10.14

*
Offer Letter Agreement, dated April 29, 2010, by and between ZELTIQ Aesthetics, Inc. and Gordon E. Nye.
 
 
 
S-1/A
 
333-175514
 
10.19

 
9/7/2011
10.15

*
Amendment to Nye Employment Agreement, dated July 11, 2011, by and between ZELTIQ Aesthetics, Inc. and Gordon E. Nye.
 
 
 
S-1/A
 
333-175514
 
10.34

 
9/7/2011
10.16

*
Offer Letter Agreement, dated November 20, 2009, by and between ZELTIQ Aesthetics, Inc. and Joshua T. Brumm.
 
 
 
S-1/A
 
333-175514
 
10.29

 
9/7/2011
10.17

*
Offer Letter Agreement, dated February 21, 2011, by and between ZELTIQ Aesthetics, Inc. and Dr. Ian P. West.
 
 
 
S-1/A
 
333-175514
 
10.30

 
9/7/2011
10.18

*
Offer Letter Agreement, dated March 24, 2011, by and between ZELTIQ Aesthetics, Inc. and Dr. Kristine N. Tatsutani.
 
 
 
S-1/A
 
333-175514
 
10.31

 
9/7/2011
10.19

*
Promotion Letter, dated August 8, 2011, by and between ZELTIQ Aesthetics, Inc. and Dr. Ian P. West.
 
 
 
S-1/A
 
333-175514
 
10.38

 
9/7/2011
10.20

*
Offer Letter Agreement, dated April 29, 2010, by and between ZELTIQ Aesthetics, Inc. and John F. Howe.
 
 
 
S-1
 
333-175514
 
10.20

 
7/13/2011
10.21

*
Promotion Letter, dated August 8, 2011, by and between ZELTIQ Aesthetics, Inc. and John F. Howe.
 
 
 
S-1/A
 
333-175514
 
10.36

 
9/7/2011
10.22

*
2005 Stock Incentive Plan.
 
 
 
S-1/A
 
333-175514
 
10.11

 
8/17/2011
10.23

*
Form of Stock Option Agreement under 2005 Stock Incentive Plan.
 
 
 
S-1/A
 
333-175514
 
10.12

 
8/17/2011
10.24

*
Amendment to 2005 Stock Incentive Plan.
 
 
 
S-1/A
 
333-175514
 
10.13

 
8/17/2011
10.25

*
2011 Equity Incentive Plan.
 
 
 
S-1/A
 
333-175514
 
10.14

 
9/23/2011
10.26

*
Form of Stock Option Agreement under 2011 Equity Incentive Plan.
 
 
 
S-1/A
 
333-175514
 
10.15

 
9/23/2011
10.27

*
Form of Restricted Stock Unit Agreement under the 2011 Stock Incentive Plan.
 
 
 
S-1/A
 
333-175514
 
10.16

 
9/23/2011
10.28

*
Form of Restricted Stock Agreement under the 2011 Stock Incentive Plan.
 
 
 
S-1/A
 
333-175514
 
10.17

 
9/23/2011
10.29

*
Form of Notice of Grant of Restricted Stock Unit under the 2011 Stock Incentive Plan.
 
 
 
S-1/A
 
333-175514
 
10.18

 
9/23/2011
10.30

*
Form of Notice of Grant of Restricted Stock under the 2011 Stock Incentive Plan.
 
 
 
S-1/A
 
333-175514
 
10.19

 
9/23/2011
10.31

*
Form of Notice of Grant of Stock Option under the 2011 Stock Incentive Plan.
 
 
 
S-1/A
 
333-175514
 
10.20

 
9/23/2011
10.32

*
2011 Employee Stock Purchase Plan.
 
 
 
S-1/A
 
333-175514
 
10.21

 
9/23/2011
10.33

*
Employment Offer Letter, dated February 20, 2012, by and between ZELTIQ Aesthetics, Inc. and Michael C. Genau.
 
 
 
8-K
 
001-35318
 
10.1

 
3/19/2012
10.34

*
Employment Offer Letter, dated February 9, 2012, by and between ZELTIQ Aesthetics, Inc. and Sergio Garcia.
 
 
 
10-Q
 
001-35318
 
10.2

 
5/11/2012
10.35

*
Severance Agreement, dated January 18, 2012, by and between ZELTIQ Aesthetics, Inc. and John F. Howe.
 
 
 
10-Q
 
001-35318
 
10.3

 
5/11/2012

5

Table of Contents

10.36

*
Promotion letter, dated February 10, 2012, by and between ZELTIQ Aesthetics, Inc. and Joshua Brumm.
 
 
 
10-Q
 
001-35318
 
10.5

 
5/11/2012
10.37

*
Cash Compensation Arrangements with Named Executive Officers.
 
 
 
10-Q
 
001-35318
 
(1)

 
5/11/2012
10.38

*
Transition Agreement, dated April 18, 2012, by and between ZELTIQ Aesthetics, Inc. and Gordie Nye.
 
 
 
10-Q
 
001-35318
 
10.7

 
8/7/2012
10.39

*
Separation Agreement, dated June 8, 2012, by and between ZELTIQ Aesthetics, Inc. and Gordie Nye.
 
 
 
10-Q
 
001-35318
 
10.8

 
8/7/2012
10.40

*
Separation Agreement, dated May 25, 2012, by and between ZELTIQ Aesthetics, Inc. and Dennis J. Jarvis.
 
 
 
10-Q
 
001-35318
 
10.9

 
8/7/2012
10.41

*
Separation Agreement, dated May 3, 2012, by and between ZELTIQ Aesthetics, Inc. and Ian P. West.
 
 
 
10-Q
 
001-35318
 
10.10

 
8/7/2012
10.42

*
Consulting Agreement, dated April 18, 2012, by and between ZELTIQ Aesthetics, Inc. and Mark J. Foley.
 
 
 
10-Q
 
001-35318
 
10.11

 
8/7/2012
10.43

*
Employment Offer Letter Agreement, dated August 23, 2012, by and between ZELTIQ Aesthetics, Inc. and Mark J. Foley.
 
 
 
10-Q
 
001-35318
 
10.12

 
11/8/2012
10.44

*
Employment Offer Letter, dated September 18, 2012, by and between ZELTIQ Aesthetics, Inc. and Len DeBenedictis.
 
 
 
10-Q
 
001-35318
 
10.13

 
11/8/2012
10.45

*
Employment Offer Letter, dated October 1, 2012, by and between ZELTIQ Aesthetics, Inc. and Keith Sullivan.
 
 
 
10-Q
 
001-35318
 
10.14

 
11/8/2012
10.46

 
Third Amendment to Office Building Lease dated August 7, 2012 by and between ZELTIQ Aesthetics, Inc. and Hacienda Portfolio Venture LLC.
 
 
 
10-Q
 
001-35318
 
10.15

 
11/8/2012
10.47

*
ZELTIQ Aesthetics, Inc. 2012 Stock Plan.
 
 
 
S-8
 
333-183131
 
99.1

 
8/7/2012
10.48

*
Compensation Arrangement with Kristine Tatsutani.
 
 
 
8-K
 
001-35318
 
(2)

 
11/19/2012
10.49

*
2012 Bonus Plan for Executive Officers.
 
 
 
8-K
 
001-35318
 
(2)

 
8/29/2012
10.50

*
Form of Stock Option Agreement Under 2012 Stock Plan.
 
X
 
 
 
 
 
 
 
 
10.51

*
Form of Restricted Stock Units Agreement Under 2012 Stock Plan.
 
X
 
 
 
 
 
 
 
 
10.52

*
Form of Restricted Stock Agreement Under 2012 Stock Plan.
 
X
 
 
 
 
 
 
 
 
10.53

*
Form of Notice of Grant of Stock Option Under 2012 Stock Plan.
 
X
 
 
 
 
 
 
 
 
10.54

*
Form of Notice of Grant of Restricted Stock Units Under 2012 Stock Plan.
 
X
 
 
 
 
 
 
 
 
10.55

*
Form of Notice of Grant of Restricted Stock Under 2012 Stock Plan.
 
X
 
 
 
 
 
 
 
 
10.56

*
Employment Offer Letter dated November 13, 2012 by and between ZELTIQ Aesthetics, Inc. and Patrick Williams.
 
X
 
 
 
 
 
 
 
 
10.57

*
Compromise Agreement dated October 26, 2012 by and between ZELTIQ Aesthetics, Inc. and Stephen Atkinson
 
X
 
 
 
 
 
 
 
 
10.58

*
Separation Agreement dated October 6, 2012 by and between ZELTIQ Aesthetics, Inc. and Richard W. Poinsett.
 
X
 
 
 
 
 
 
 
 
10.59

*
Directors Compensation Arrangements.
 
X
 
 
 
 
 
 
 
 
21.1

 
List of subsidiaries.
 
X
 
 
 
 
 
 
 
 

6

Table of Contents

23.1

 
Consent of PricewaterhouseCoopers LLP, Independent Registered Public Accounting Firm.
 
X
 
 
 
 
 
 
 
 
24.1

 
Power of Attorney (see signature page to this Form 10-K).
 
X
 
 
 
 
 
 
 
 
31.1

 
Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
 
X**
 
 
 
 
 
 
 
 
31.2

  
Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
 
X**
 
 
 
 
 
 
 
 
32.1

  
Certification of Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
 
X
 
 
 
 
 
 
 
 
101.INS

  
XBRL Instance Document
 
X
 
 
 
 
 
 
 
 
101.SCH

 
XBRL Taxonomy Extension Schema
 
X
 
 
 
 
 
 
 
 
101.CAL

 
XBRL Taxonomy Extension Calculation Linkbase
 
X
 
 
 
 
 
 
 
 
101.DEF

 
XBRL Taxonomy Extension Definition Linkbase
 
X
 
 
 
 
 
 
 
 
101.LAB

 
XBRL Taxonomy Extension Label Linkbase
 
X
 
 
 
 
 
 
 
 
101.PRE

 
XBRL Taxonomy Extension Presentation Linkbase
 
X
 
 
 
 
 
 
 
 
 ______________________
#
Portions of this exhibit have been omitted and filed separately with the Securities and Exchange Commission.
*
Management Compensation Plan or Arrangement
**
Corrected exhibits filed herewith are dated as of the date of the original exhibits
(1)
As described in Item 5 of the Form 10-Q
(2)
As described in Item 5.02 of the Form 8-K



EXHIBIT INDEX
(To Form 10-K/A)
 
Exhibit No.
 
Description
31.1.1
 
Certification of Principal Executive Officer Required Under Rule 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as amended.
31.1.2
 
Certification of Principal Financial Officer Required Under Rule 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as amended.





7


Exhibit 31.1
CERTIFICATION
I, Mark J. Foley, certify that:
    1.    I have reviewed this Form 10-K of ZELTIQ Aesthetics, Inc.;
    2.    Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
    3.    Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
    4.    The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
    (a)    Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
    (b)    Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)    Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
    (d)    Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
    5.    The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
    (a)    All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
    (b)    Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

March 13, 2013
 
/s/ Mark J. Foley
Mark J. Foley
President and Chief Executive Officer
(Principal Executive Officer)





Exhibit 31.2
CERTIFICATION
I, Patrick F. Williams, certify that:
    1.    I have reviewed this Form 10-K of ZELTIQ Aesthetics, Inc.;
    2.    Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
    3.    Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
    4.    The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
    (a)    Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
    (b)    Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)    Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
    (d)    Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
    5.    The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
    (a)    All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
    (b)    Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

March 13, 2013
 
/s/ Patrick F. Williams
Patrick F. Williams
Chief Financial Officer
(Principal Financial and Accounting Officer)





Exhibit 31.1.1
CERTIFICATION
I, Mark J. Foley, certify that:
1.
I have reviewed this Form 10-K/A of ZELTIQ Aesthetics, Inc.; and
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.

August 7, 2013
 
 
/s/ Mark J. Foley
Mark J. Foley
President and Chief Executive Officer
(Principal Executive Officer)





Exhibit 31.1.2
CERTIFICATION
I, Patrick F. Williams, certify that:
1.
I have reviewed this Form 10-K/A of ZELTIQ Aesthetics, Inc.; and
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.

August 7, 2013
 
 
/s/ Patrick F. Williams
Patrick F. Williams
Senior Vice President and Chief Financial Officer
(Principal Financial and Accounting Officer)